Allergy Diagnostics Nextmune focuses on diagnostic tools for pet and horse allergies with a patented approach, presenting a primary opportunity to upsell expanded allergen panels and advanced treatment options to clinics already using their testing services.

Test and Treat Launch of the Test and Treat Package bundles an allergen serum testing panel with initial treatment at a single price, creating a compelling cross-sell and high-value entry point for clinics seeking cost-effective, streamlined adoption of Nextmune solutions.

Small to Mid Market Company size (11-50 employees) and relative revenue profile ($0-1M) indicate potential for scalable partnerships with regional veterinary clinics and specialty practices that can serve as early adopters and channel partners for growth initiatives.

Customer Service Focus Emphasis on exceptional customer service, tools, and support suggests strong service-led differentiation; leverage this to position Nextmune as a preferred supplier in competitive bidding for clinic networks and veterinary groups.

Growth through Partnerships With a long-standing 30-year history and ongoing initiatives, there is an opportunity to expand distribution through clinics, referral networks, and potential collaborations with larger industry players to accelerate market reach and recurring revenue.